Usefulness of Nonvalved Spacers for Administration of Inhaled Steroids in Young Children with Recurrent Wheezing and Risk Factors for Asthma

<div>Percentage days with respiratory symptoms of children receiving FP 125 mcg BID with MDI plus VHC and NVS for 6 months.</div>

Canadian Respiratory Journal

fig2

Figure 2

Figure 2: Usefulness of Nonvalved Spacers for Administration of Inhaled Steroids in Young Children with Recurrent Wheezing and Risk Factors for Asthma 

Figure 2 | Usefulness of Nonvalved Spacers for Administration of Inhaled Steroids in Young Children with Recurrent Wheezing and Risk Factors for Asthma 